Navigation Links
Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Date:4/10/2008

activity of a new PI3K inhibitor PX-866 for

treatment of human glioblastoma

Abstract # 3731, Session: Imaging in Preclinical and Clinical

Therapeutics

Poster Session: Tuesday, April 15, 2008, 8:00 a.m. to

12:00 p.m. PT

- Identification of novel synergistic targets RACK-1 and galectin-1 for

rational drug combinations with PI3 Kinase inhibitors using siRNA

synthetic lethality screening

Abstract # 2761, Session: Signal Transduction and Therapeutics

Poster Session: Monday, April 14, 2008, 1:00 p.m. to

5:00 p.m. P.T.

- Phosphatidylinositol 3-kinase stimulates the proliferation of

bronchioalveolar stem cells in mouse models of oncogenic K-ras-

induced lung cancer

Abstract # 5408, Session: Stem Cells

Poster Session: Wednesday, April 16, 2008, 8:00 a.m. to

12:00 p.m. P.T.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.

Forward Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements related to future clinical development plans for PX-12 and PX-866. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events an
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncothyreon announces effectiveness of shelf registration statement
2. Oncothyreon announces issuance of patent for PX-867
3. Oncothyreon to present at upcoming investment conferences
4. Oncothyreon reports full year and fourth quarter 2007 financial results
5. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
6. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
7. Oncothyreon launches new corporate website
8. Oncothyreon to present at BIO CEO & Investor Conference
9. Oncothyreon highlights corporate and clinical objectives for 2008
10. Biomira announces plan to change name to Oncothyreon
11. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...of Financial Executives International , a 15,000-...emics, and audit committee members, has announced ...community influence. , ,The group offers an opport...about the ethics, highest standards, and best prac...t the business dynamics of the Madison area are di...
...ates Air Force contract to fund the development of...vide a Madison aerospace research and product deve...ld enable it to propel something much larger. , ,T...d $3.9 million to Orbital Technologies Corp. (Or...le, but it might issue additional delivery orders ...
...mn by Geoff Bastow , will dissect topics that i... community, including: entrepreneurship in IT, in...nd technology trends that are driving real busine...kee, Wis. - At the dawn of the dot-com era and t...March of 2000, Kenosha entrepreneur John Weiss was...
...classified contract from the defense sector, Plex...ered here, reported record revenues and earnings f...spite the closing of its manufacturing facility in...mpered, however, by forecasts of lower-than-expect...s stock price to fall by roughly one-third. , ,Rev...
Other Biology Technology:Orbitec will use $25 million Air Force contract to make small launch vehicle 2Leadership insights from co-founder of Yesmail 2Leadership insights from co-founder of Yesmail 3Leadership insights from co-founder of Yesmail 4Leadership insights from co-founder of Yesmail 5Defense contract helps Plexus gain record profits 2
(Date:7/24/2008)...s could talk, they might tell potential suitors, "...lltale come slither look. But worms send their val... chemical code researchers are now cracking, accor...he journal Nature . , Scientists from the Univ...nia Institute of Technology and the U.S. Departmen...
(Date:7/24/2008)... typhoon in Taiwan buries as much carbon in the oc... rains in that country all year long combined. ,...tudy published in a recent issue of the journal G...e the chemistry of stream water and sediments that...happening at full force -- will help scientists de...
(Date:7/23/2008)...tions willing to collectively spend about $1 billi...half a billion metric tons of carbon dioxide per y... , It would take about that much money to put an...he world, one of the top contributors to greenhous...ted, this type of program could have potential to ...
(Date:7/23/2008)... Institute of Standards and Technology (NIST) have... clumps of proteins in protein-based pharmaceutica...ditions under which scientists can be assured that...rmation of protein aggregates, a major concern bec...n biologic drug manufacturing. , Proteins, a mai...
Breaking Biology News(10 mins):Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4NIST trumps the clumps: Making biologic drugs safer 2BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 1BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 2BioNanomatrix Announces Appointment of Paul R Selvin to Its Scientific Advisory Board 4984 3Melanoma of the rectum 3A A rare entity 18032 1Determined a new method to establish the antioxidant capacity of extra virgin olive oil 18029 1Determined a new method to establish the antioxidant capacity of extra virgin olive oil 18029 2Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 1Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 2Ancient Nutcracker Man challenges ideas on evolution of human diet 3116 3
... made massive changes to the Earth,s landscape , ...andscape. But what was happening below the ice in ...s that it was a time of mass destruction as whole ...s scouring the sea floor. , In the past it has be...tinction by recolonising from nearby habitats that...
...n of airplanes from the Wright Brothers, first bip...he much earlier evolution of dinosaur flight, say ...ogist Sankar Chatterjee and retired aeronautical e...ur called Microraptor gui used a two-level, biplan...he early Cretaceous. Among the evidence for the ea...
...e of the tropics unfolds, scientists must explain ...to rapid human-population increase and environment...n the world increase, tropical forests are changin...ed, burned, logged, fragmented, and overhunted and...tered in insidious ways by global climatic and atm...
...suggests that restoring a gene often silenced in l...findings could lead to a new strategy for treating...own as WWOX, which is lost or silenced in a large ...east, ovary, prostate, bladder, esophagus and panc...tate University Comprehensive Cancer Center ? Arth...
Other Biology News:Seafloor creatures destroyed by ice action during ice ages 2Wright bros. upstaged! Dinos invented biplanes 2Wright bros. upstaged! Dinos invented biplanes 3Scientists must offer solutions for conserving tropical forests in a rapidly changing world 2Restoring silenced suppressor gene kills lung-cancer cells 2
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C
Request Info
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture.
Biology Products: